Cleared Traditional

K051499 - INTRAVASCULAR ADMINISTRATION SET AND EXTENSION SET

K051499 is an FDA 510(k) clearance for INTRAVASCULAR ADMINISTRATION SET AND EX..., manufactured by Medegen Medical Manufacturing Services. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K051499 · Medegen Medical Manufacturing Services · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2005
Decision
15d
Days
Class 2
Risk

K051499 is an FDA 510(k) clearance for the INTRAVASCULAR ADMINISTRATION SET AND EXTENSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medegen Medical Manufacturing Services (Trabuco Canyon, US). The FDA issued a Cleared decision on June 22, 2005 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medegen Medical Manufacturing Services devices

FDA 510(k) Submission Details - K051499

510(k) Number K051499 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2005
Decision Date June 22, 2005
Days to Decision 15 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d faster than avg
Panel avg: 129d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 879
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K051499.
MAXPLUS TRU-SWAB POSITIVE DISPLACEMENT CONNECTOR
K051939 · Medegen Medical Manufacturing System · Aug 2005
ANGIODYNAMICS TUMESCENT INFUSION DEVICE
K051142 · AngioDynamics, Inc. · Jul 2005
HUBER CLEAR SAFETY INFUSION SET
K051009 · Now Medical Distribution, Inc. · Jul 2005
MINILOC SAFETY INFUSION SET
K050600 · Specialized Health Products, Intl. · May 2005
PENTADEFLUE IV SOLUTION ADMINISTRATION SETS
K041495 · Pentaferte S.P.A · Apr 2005
MICROFLO-SAFE SCALP VEIN SET
K043328 · Dks Loversan Industria Biomedica Spa · Apr 2005

FDA 510(k) Resources - General Hospital

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.